Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia
Company plans to begin 30-patient trial later this year BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (NASDAQ:…